Spots Global Cancer Trial Database for neoplasms, lung
Every month we try and update this database with for neoplasms, lung cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung | NCT03603652 | Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Carcinoma, Non-... Non-Small Cell ... Non-Small-Cell ... | Microwave Ablat... | 18 Years - | Ethicon, Inc. | |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer | NCT02410603 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer | NCT00653939 | Tumors | Fosbretabulin Carboplatin Paclitaxel Bevacizumab | 18 Years - | Mateon Therapeutics | |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | NCT00042679 | Carcinoma, Non-... Pulmonary Neopl... Neoplasms, Lung | Gemcitabine Carboplatin LY900003 | 18 Years - | Eli Lilly and Company | |
| A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | NCT00042679 | Carcinoma, Non-... Pulmonary Neopl... Neoplasms, Lung | Gemcitabine Carboplatin LY900003 | 18 Years - | Eli Lilly and Company | |
| Study of ESG401 in Adults With Solid Tumors | NCT04892342 | Neoplasms, Brea... Neoplasms, Lung Neoplasms,Color... Neoplasms, Blad... Neoplasm of Sto... Neoplasms,Ovari... | ESG401 | 18 Years - 75 Years | Shanghai Escugen Biotechnology Co., Ltd | |
| A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer | NCT00653939 | Tumors | Fosbretabulin Carboplatin Paclitaxel Bevacizumab | 18 Years - | Mateon Therapeutics | |
| A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | NCT01131429 | Neoplasms, Lung Carcinoma, Non-... Drug Therapy Genes, EGFR | Erlotinib Docetaxel Cisplatin Docetaxel Cisplatin Erlotinib | 18 Years - | Chinese PLA General Hospital | |
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine | NCT02115958 | Neoplasms, Lung | cancer stem cel... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
| Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer | NCT05132075 | Non-Small Cell ... | JDQ443 docetaxel | 18 Years - | Novartis | |
| The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine | NCT02115958 | Neoplasms, Lung | cancer stem cel... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | NCT01131429 | Neoplasms, Lung Carcinoma, Non-... Drug Therapy Genes, EGFR | Erlotinib Docetaxel Cisplatin Docetaxel Cisplatin Erlotinib | 18 Years - | Chinese PLA General Hospital | |
| Incidence of Postthoracotomy Pain Following General Anesthesia: A Comparison Between TIVA and Inhalation Anesthesia | NCT00935571 | Lung Cancer Neoplasms, Lung | propofol, remif... | 18 Years - | Asan Medical Center | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer | NCT05132075 | Non-Small Cell ... | JDQ443 docetaxel | 18 Years - | Novartis | |
| Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | NCT00290017 | Carcinoma, Non-... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... | talabostat pemetrexed | 18 Years - | Point Therapeutics | |
| MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) | NCT02673021 | Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Metastatic Canc... | Microwave ablat... | 18 Years - | Mayo Clinic | |
| Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT04699188 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Colo... Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | JDQ443 TNO155 tislelizumab | 18 Years - | Novartis | |
| NEUWAVE Flexible Probe Study #2 | NCT03713099 | Cancer of the L... Lung Cancer Neoplasms, Lung Carcinoma, Non-... Non-Small Cell ... Non-Small Cell ... | Microwave ablat... | 18 Years - | Ethicon, Inc. | |
| A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology | NCT02512757 | Lung Cancer | 18 Years - 79 Years | Innovis LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
